ThePICenter.com: A Nationwide Network of Legal Representation for Accidents and Injuries Home | Refer to a Friend | Contact Us | Attorney Log-In
ThePICenter - The Personal Injury Center  

Call us today: 877.888.5936 
 Cases We Handle  Why Choose Us  About Us  Client Services  Frequently Asked Questions   Free Case Evaluation - Submit Your Case
Abilify
Has Abilify Caused You Or A Loved One Harm?
Fill Out The Form Below For A Free Evaluation
 
Areas of Expertise
Accidents
Consumer Fraud
Medical Malpractice
Toxic Substances
Unsafe Drugs
Unsafe Products
 
Have a case, but would like to speak with us directly?
 
Call us today: 877.888.5936
 
Click here to receive your free evaluation
 
Unsafe Drugs :: Abilify

ABILIFY - WE ARE NO LONGER ACCEPTING ABILIFY INQUIRIES OR CASES!

In late 2003 the Food and Drug Administration approved the use of the drug Aripiprazole, which is better known to the public as the prescription medication Abilify. Manufactured by both Bristol-Myers Squibb Co. and Otsuka America Pharmaceuticals Inc., Abilify is available in a variety of forms including oral tablets, an oral solution, or as an injection solution for intramuscular injection. Used to treat schizophrenia and more recently approved for bipolar disorder and depression, Abilify is certainly not without its share of potentially serious side effects.

First of all, it is important to understand that the risk of suicidal thoughts and suicidal behavior, especially in adolescents and young adults is much more prevalent in patients that have been using any kind of anti-depressant medication, Abilify included. Because of this, it is recommended that Abilify only be taken by those that are at least 24 years of age or older.  Prescribing the drug to someone younger than that may be medical malpractice.  And prescribing the drug Abilify without prescribing other drugs first, may be medical malpractice.  Abilify should only be prescribed as a last resort and with great care.

It is also important to note that an increased mortality rate has been seen amongst dementia patients who use prescription anti-depressants or antipsychotics, including the drug Abilify. Evidence can be seen in this from the results of 10-week clinical trial where it was found that the rate of death amongst those who had been treated with an anti-depressant was almost 2% higher than those who had only taken a placebo; researchers say this is particularly prevalent amongst elderly women.

Other studies have revealed even more dangers associated with Abilify and other antipsychotics and anti-depressant medication. This includes an increased risk of stroke, Hyperglycemia and Diabetes Mellitus amongst elderly patients, as well.

The best thing that you or a loved one can do before taking any kind of medication, whether it is over-the-counter or prescription is to properly educate yourself on the drug; no matter how innocent it may seem. For some it is too late, however – and if you or someone you know has suffered from any of the serious side effects that are associated with the drug Abilify, it is important that you seek out the appropriate legal help immediately.

Court cases dealing with potential death as a result of Abilify or any other drug are an important matter, and this is a legal issue that requires the serious and professional attention of a fully-qualified Abilify attorney. Fill out our form below for a free case evaluation and analysis by experienced attorneys working on Abilify lawsuits. 

Keywords: Abilify | Abilify Tardive Dyskinesia | Abilify Attorneys | Abilify Lawsuit | Abilify Law Firm
 

Free Case Evaluation

Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.

Your Name:
Your Address:
Your City:
Your State:
Your Zipcode:
Your Email:
Your Phone Number:
Your Fax Number:
Date of Injury:  
Location of Injury:  
If this inquiry is not for yourself, please tell us the name of the person injured:
Your relationship to this person:
 
Details of Injury:
   
Enter the code shown:

Please note, this form may take a few seconds to process after the Submit Case button is pressed.
 


Abilify In the News

Common Parkinson's Drugs Linked to Pathological Gambling and Hypersexuality - Mad In America
Common Parkinson's Drugs Linked to Pathological Gambling and HypersexualityMad In AmericaThe partial agonist antipsychotic medication aripiprazole (Abilify) was one of the drugs identified as problematic. The paper...
More Information »



FDA Approves New Formulation for Abilify Maintena - Monthly Prescribing Reference
FDA Approves New Formulation for Abilify MaintenaMonthly Prescribing ReferenceOtsuka and Lundbeck announced that the Food and Drug Administration (FDA) has approved Abilify Maintena (aripiprazole) for extended-release...
More Information »



Alkermes' (ALKS) CEO Rich Pops on Q3 2014 Results - Earnings Call Transcript ... - Seeking Alpha (registration)
Alkermes' (ALKS) CEO Rich Pops on Q3 2014 Results - Earnings Call Transcript ...Seeking Alpha (registration)With the PDUFA date in November, for the schizoaffective disorder indication for INVEGA SUSTENNA and the expected...
More Information »



FDA to Review Aripiprazole Lauroxil NDA for Schizophrenia - Monthly Prescribing Reference
FDA to Review Aripiprazole Lauroxil NDA for SchizophreniaMonthly Prescribing ReferenceThe NDA filing included positive results from the randomized, multicenter, double-blind, placebo-controlled Phase 3 study assessing the...
More Information »



What Are The Best-Selling Drugs Of 2014? - Benzinga
What Are The Best-Selling Drugs Of 2014?BenzingaAbilify, which has the generic name aripiprazole, is a partial dopamine agonist. It belongs to the second-generation class of antipsychotics. The drug has ... Aripiprazole was...
More Information »



Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.? - DailyFinance
DailyFinanceBetter Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?DailyFinanceBy 2015, Bristol-Myers will also be staring down the exclusivity loss of schizophrenia drug Abilify, which is on pace to deliver...
More Information »



Drug Manufacturers – Specific & Generic - MSN Money
Drug Manufacturers – Specific & GenericMSN MoneyNUEDEXTA is the first and only FDA-approved treatment for pseudobulbar affect. NUEDEXTA is an combination of two components: ... NUEDEXTA may face competition from several...
More Information »



Gröhe und die nackte Wahrheit - APOTHEKE ADHOC
Gröhe und die nackte WahrheitAPOTHEKE ADHOCRabattvertrag für Reimport: Die AOK Rheinland-Hamburg und die AOK Nordost haben für Abilify Vereinbarungen mit Kohl, Milinda und Heptagon geschlossen. Foto: APOTHEKE ADHOC. Schnell...
More Information »



BMS '스프라이셀ㆍ여보이' 기대 이상 - 의약뉴스
BMS '스프라이셀ㆍ여보이' 기대 이상의약뉴스미국 제약회사 브리스톨마이어스스퀴브(BMS)는 몇몇 주요 약물의 높은 매출 덕분에 올해 3분기 실적이 예상을 웃돌았다고 발표했다. 아스트라제네카에게 매각한 당뇨병 사업부의 매출을 제외한 BMS의 3분기 순매출은 항암제 분야의 제품 매출이 증가함에 따라 작년 ...and more »
More Information »



Savvy Senior: Off-brand drugs can offer seniors some big savings - Yuma Sun
Savvy Senior: Off-brand drugs can offer seniors some big savingsYuma SunTo gain approval from the U.S. Food and Drug Administration (FDA), generic drugs are required to the same active ingredient, strength, dosage form and...
More Information »



$9.7B Major Depressive Disorder Treatment Market Sales Forecast to 2023 - PR Newswire (press release)
$9.7B Major Depressive Disorder Treatment Market Sales Forecast to 2023PR Newswire (press release)This can be attributed mainly to the expirations of patents for Eli Lilly's Cymbalta, Otsuka Pharmaceutical/BMS'...
More Information »



Sværvægtsaktier holdt C20 i skak - Børsen Online
Børsen OnlineSværvægtsaktier holdt C20 i skakBørsen OnlineAktien lukkede i 159,80 efter et fald på 0,8 pct. Lundbecks japanske partner, Otsuka, har hos de amerikanske sundhedsmyndigheder (FDA) fået godkendt en to-kammer...
More Information »



Aktier: Novo siver fra rekordniveau - Børsen Online
Aktier: Novo siver fra rekordniveauBørsen OnlineDet danske aktiemarked åbner lidt højere tirsdag, hvor stemningen på de internationale finansmarkeder i høj grad er præget af demonstrationer i Hong Kong, der skaber en vis...
More Information »

 









 
Aviation Accidents| Car Accidents| Truck Accidents| Birth Injuries| Nursing Home Negligence| Mesothelioma| Defective Medical Devices
Copyright 2011 The Personal Injury Center of AmericaTM All Rights Reserved.
The Personal Injury Center of AmericaTM is proud to serve clients in New York, Los Angeles, Chicago, Houston, Philadelphia, and throughout the nation.